Home/Glyscend Therapeutics/Sapan A. Shah, Ph.D.

SA

Sapan A. Shah, Ph.D.

Chief Executive Officer

Glyscend Therapeutics

Therapeutic Areas

Metabolic Gastrointestinal

Glyscend Therapeutics Pipeline

Drug	Indication	Phase
GLY-200	Obesity	Phase 2